Finance

Lists
Why is IBO up 2,18%?
Dive Deeper
IBO:NYSEAMERICAN
Impact Biomedical Inc
4,21 $
+2,18%
(+0,090) 1D
9 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IBO...
Open
4,13 $
High
4,39 $
Low
4,13 $
Mkt. cap
35,97 մլն
Volume
4,03 հզր
52-wk high
10,47 $
52-wk low
4,06 $
EPS
-1,13 $
Shares outstanding
8,54 մլն
No. of employees
2
Open
4,13 $
High
4,39 $
Low
4,13 $
Mkt. cap
35,97 մլն
Volume
4,03 հզր
52-wk high
10,47 $
52-wk low
4,06 $
EPS
-1,13 $
Shares outstanding
8,54 մլն
No. of employees
2
News stories
From web sources and news partners
About Impact Biomedical Inc
CEO-
Employees2
Founded2018
HeadquartersՀյուստոն, Տեխաս, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
18,00 հզր
7,00 հզր
7,00 հզր
3,00 հզր
Cost of goods sold
1,00 հզր
422,00 հզր
-
1,00 հզր
Cost of revenue
1,00 հզր
422,00 հզր
-
1,00 հզր
Research and development expenses
52,00 հզր
110,00 հզր
46,00 հզր
76,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
516,00 հզր
275,00 հզր
1,90 մլն
277,00 հզր
Operating expense
965,00 հզր
743,00 հզր
2,30 մլն
704,00 հզր
Total operating expenses
966,00 հզր
1,16 մլն
2,30 մլն
705,00 հզր
Operating income
-948,00 հզր
-1,16 մլն
-2,29 մլն
-702,00 հզր
Other non operating income
-268,00 հզր
3,82 մլն
-
-
EBT including unusual items
-1,48 մլն
2,66 մլն
-2,28 մլն
-700,00 հզր
EBT excluding unusual items
-1,48 մլն
2,67 մլն
-2,28 մլն
-700,00 հզր
Income tax expense
-
-2,58 մլն
-
-
Effective tax rate
-
-97,18%
-
-
Other operating expenses
109,00 հզր
72,00 հզր
67,00 հզր
67,00 հզր
Net income
-1,47 մլն
5,24 մլն
-2,29 մլն
-699,00 հզր
Net profit margin
-8 166,67%
74 928,57%
-32 671,43%
-23 300,00%
Earnings per share
-
-
-
-
Interest and investment income
3,00 հզր
3,00 հզր
5,00 հզր
2,00 հզր
Interest expense
-262,00 հզր
-
-
-
Net interest expenses
-259,00 հզր
3,00 հզր
5,00 հզր
2,00 հզր
Depreciation and amortization charges
288,00 հզր
286,00 հզր
285,00 հզր
284,00 հզր
EBITDA
-92,00 հզր
-872,00 հզր
-2,00 մլն
-418,00 հզր
Gain or loss from assets sale
-
12,00 հզր
-
-
AI content may include mistakes. Learn more
Google Apps